The arrival of this medication in Oz is generating significant interest within the weight loss community. This novel dual medication – targeting both GLP-1 and GIP receptors – presents a remarkably effective option https://hubwebsites.com/story23598602/new-retatrutide-australia-a-possible-new-solution-for-body-management